Novartis AG vs Skyworks Solutions Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Skyworks Solutions Inc trades at $62.81 (market cap $8.99B). The key difference: Novartis AG is far larger — about 32.3× Skyworks Solutions Inc's market cap, and Skyworks Solutions Inc pays the higher dividend (4.75%). Which is the better fit depends on your goals.
| NVS | SWKS | |
|---|---|---|
Market Cap | $290.25B | $8.99B |
Sector | Health | Technology |
52-Week High | $168.62 | $83.40 |
52-Week Low | $113.50 | $52.50 |
Enterprise Value | $330.27B | $8.76B |
Dividend Yield | 3.17% | 4.75% |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →